Andrew Benson has extensive experience in the field of operations and investor relations, currently serving in an Investor Relations role at Co-Diagnostics, Inc since February 2014. Co-Diagnostics is known for its innovative molecular diagnostics technology, which utilizes unique mathematical models to create cost-effective and rapid DNA-based tests. Prior to this position, Andrew Benson held the title of Director of Operations at Legends Capital LLC from February 2007 to February 2014. Andrew Benson holds a Master of Philosophy degree in Linguistics from the University of Cambridge.